Literature DB >> 8130373

Expression of the dystrophin-related protein (utrophin) gene during mouse embryogenesis.

J Schofield1, D Houzelstein, K Davies, M Buckingham, Y H Edwards.   

Abstract

The utrophin (UTRN) locus is the autosomal homologue of the DMD (Duchenne muscular dystrophy) gene and encodes a protein, utrophin which is thought to be upregulated in the absence of dystrophin. In this study the spatial and temporal expression of the UTRN gene has been examined during mouse embryogenesis and compared with that of the DMD gene. The patterns of expression of these two genes are very different. Whilst DMD is expressed largely in mesodermal derivatives such as cardiac and striated muscle, UTRN shows a more widespread distribution and is expressed in neural tube, tissues which originate from neural crest and a variety of other sites of non-neural origin. In early embryos UTRN transcripts initially accumulate in the mid-neural plate and thereafter in the caudal neural tube. UTRN mRNA then becomes abundant in a subset of neural crest cell derived tissues, in particular the spinal and facial ganglia and ossifying facial cartilages. UTRN is also expressed in a variety of other sites and organs such as the tendon primordia in the digits, the pituitary, thyroid and adrenal glands, cardiac muscle, kidney and lung, follicles of the vibrissae and the outflow tract of the heart. Several patterns of UTRN expression are apparent and we discuss the possibility that these can be ascribed to a family of mRNAs transcribed from the UTRN gene using alternative promoters.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8130373     DOI: 10.1002/aja.1001980403

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  26 in total

1.  Developmental microRNA expression profiling of murine embryonic orofacial tissue.

Authors:  Partha Mukhopadhyay; Guy Brock; Vasyl Pihur; Cynthia Webb; M Michele Pisano; Robert M Greene
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-07

Review 2.  Progress in gene therapy of dystrophic heart disease.

Authors:  Y Lai; D Duan
Journal:  Gene Ther       Date:  2012-02-09       Impact factor: 5.250

3.  Changes in mechanosensitive channel gating following mechanical stimulation in skeletal muscle myotubes from the mdx mouse.

Authors:  Alfredo Franco-Obregón; Jeffry B Lansman
Journal:  J Physiol       Date:  2002-03-01       Impact factor: 5.182

4.  2015 William Allan Award.

Authors:  Kay E Davies
Journal:  Am J Hum Genet       Date:  2016-03-03       Impact factor: 11.025

5.  The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy.

Authors:  K J Perkins; E A Burton; K E Davies
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

6.  Molecular and functional analysis of the utrophin promoter.

Authors:  C L Dennis; J M Tinsley; A E Deconinck; K E Davies
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

7.  Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation.

Authors:  Deborah Merrick; Lukas Kurt Josef Stadler; Dean Larner; Janet Smith
Journal:  Dis Model Mech       Date:  2009-06-17       Impact factor: 5.758

8.  Targeting artificial transcription factors to the utrophin A promoter: effects on dystrophic pathology and muscle function.

Authors:  Yifan Lu; Chai Tian; Gawiyou Danialou; Rénald Gilbert; Basil J Petrof; George Karpati; Josephine Nalbantoglu
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

9.  G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain.

Authors:  D J Blake; J N Schofield; R A Zuellig; D C Górecki; S R Phelps; E A Barnard; Y H Edwards; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

Review 10.  Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.

Authors:  Kristin Wilson; Crystal Faelan; Janet C Patterson-Kane; Daniel G Rudmann; Steven A Moore; Diane Frank; Jay Charleston; Jon Tinsley; G David Young; Anthony J Milici
Journal:  Toxicol Pathol       Date:  2017-10-03       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.